145 related articles for article (PubMed ID: 33175152)
1. RUNX1 promotes MAPK signaling to increase tumor progression and metastasis via OPN in head and neck cancer.
Liu K; Hu H; Jiang H; Zhang H; Gong S; Wei D; Yu Z
Carcinogenesis; 2021 Apr; 42(3):414-422. PubMed ID: 33175152
[TBL] [Abstract][Full Text] [Related]
2. Elevated RUNX1 is a prognostic biomarker for human head and neck squamous cell carcinoma.
Feng X; Zheng Z; Wang Y; Song G; Wang L; Zhang Z; Zhao J; Wang Q; Lun L
Exp Biol Med (Maywood); 2021 Mar; 246(5):538-546. PubMed ID: 33241710
[TBL] [Abstract][Full Text] [Related]
3. Loss of TP63 Promotes the Metastasis of Head and Neck Squamous Cell Carcinoma by Activating MAPK and STAT3 Signaling.
Lakshmanachetty S; Balaiya V; High WA; Koster MI
Mol Cancer Res; 2019 Jun; 17(6):1279-1293. PubMed ID: 30910837
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of secreted phosphoprotein 1 affects malignant progression, prognosis, and resistance to cetuximab via the KRAS/MEK pathway in head and neck cancer.
Liu K; Hu H; Jiang H; Liu C; Zhang H; Gong S; Wei D; Yu Z
Mol Carcinog; 2020 Oct; 59(10):1147-1158. PubMed ID: 32805066
[TBL] [Abstract][Full Text] [Related]
5. CD147 promotes progression of head and neck squamous cell carcinoma via NF-kappa B signaling.
Yu B; Zhang Y; Wu K; Wang L; Jiang Y; Chen W; Yan M
J Cell Mol Med; 2019 Feb; 23(2):954-966. PubMed ID: 30421493
[TBL] [Abstract][Full Text] [Related]
6. UBE2C promotes the progression of head and neck squamous cell carcinoma.
Jin Z; Zhao X; Cui L; Xu X; Zhao Y; Younai F; Messadi D; Hu S
Biochem Biophys Res Commun; 2020 Mar; 523(2):389-397. PubMed ID: 31870550
[TBL] [Abstract][Full Text] [Related]
7. miR-375 Regulates Invasion-Related Proteins Vimentin and L-Plastin.
Jimenez L; Lim J; Burd B; Harris TM; Ow TJ; Kawachi N; Belbin TJ; Angeletti R; Prystowsky MB; Childs G; Segall JE
Am J Pathol; 2017 Jul; 187(7):1523-1536. PubMed ID: 28499703
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of ZEB2-AS1 promotes epithelial-to-mesenchymal transition and metastasis by stabilizing ZEB2 mRNA in head neck squamous cell carcinoma.
Diao P; Ge H; Song Y; Wu Y; Li J; Li Z; Yang J; Wang Y; Cheng J
J Cell Mol Med; 2019 Jun; 23(6):4269-4280. PubMed ID: 30950191
[TBL] [Abstract][Full Text] [Related]
9. Rh type C-glycoprotein functions as a novel tumor suppressor gene by inhibiting tumorigenicity and metastasis in head and neck squamous cell carcinoma.
Xu W; Zou H; Wei Z; Song C; Tang C; Yin X; Wang Y; Han S; Cai Y; Han W
Aging (Albany NY); 2019 Jun; 11(11):3601-3623. PubMed ID: 31170090
[TBL] [Abstract][Full Text] [Related]
10. OPN up-regulated proliferation and invasion of head and neck squamous cell carcinoma through the p38MAPK signaling pathway.
Yu X; Du Y; Liang S; Zhang N; Jing S; Sui L; Kong Y; Dong M; Kong H
Oral Surg Oral Med Oral Pathol Oral Radiol; 2023 Jul; 136(1):70-79. PubMed ID: 37286411
[TBL] [Abstract][Full Text] [Related]
11. Distinct roles of PIK3CA in the enrichment and maintenance of cancer stem cells in head and neck squamous cell carcinoma.
Chen X; Cao Y; Sedhom W; Lu L; Liu Y; Wang H; Oka M; Bornstein S; Said S; Song J; Lu SL
Mol Oncol; 2020 Jan; 14(1):139-158. PubMed ID: 31600013
[TBL] [Abstract][Full Text] [Related]
12. LncRNA LINC00460 promotes EMT in head and neck squamous cell carcinoma by facilitating peroxiredoxin-1 into the nucleus.
Jiang Y; Cao W; Wu K; Qin X; Wang X; Li Y; Yu B; Zhang Z; Wang X; Yan M; Xu Q; Zhang J; Chen W
J Exp Clin Cancer Res; 2019 Aug; 38(1):365. PubMed ID: 31429766
[TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA MYOSLID promotes invasion and metastasis by modulating the partial epithelial-mesenchymal transition program in head and neck squamous cell carcinoma.
Xiong HG; Li H; Xiao Y; Yang QC; Yang LL; Chen L; Bu LL; Zhang WF; Zhang JL; Sun ZJ
J Exp Clin Cancer Res; 2019 Jun; 38(1):278. PubMed ID: 31238980
[TBL] [Abstract][Full Text] [Related]
14. Suppression of migration, invasion, and metastasis of cisplatin-resistant head and neck squamous cell carcinoma through IKKβ inhibition.
Liao J; Yang Z; Carter-Cooper B; Chang ET; Choi EY; Kallakury B; Liu X; Lapidus RG; Cullen KJ; Dan H
Clin Exp Metastasis; 2020 Apr; 37(2):283-292. PubMed ID: 32020377
[TBL] [Abstract][Full Text] [Related]
15. Carbonyl reductase 1 is a new target to improve the effect of radiotherapy on head and neck squamous cell carcinoma.
Yun M; Choi AJ; Lee YC; Kong M; Sung JY; Kim SS; Eun YG
J Exp Clin Cancer Res; 2018 Oct; 37(1):264. PubMed ID: 30376862
[TBL] [Abstract][Full Text] [Related]
16. SUZ12 is a novel putative oncogene promoting tumorigenesis in head and neck squamous cell carcinoma.
Wu Y; Hu H; Zhang W; Li Z; Diao P; Wang D; Zhang W; Wang Y; Yang J; Cheng J
J Cell Mol Med; 2018 Jul; 22(7):3582-3594. PubMed ID: 29667751
[TBL] [Abstract][Full Text] [Related]
17. HOXB5 acts as an oncogenic driver in head and neck squamous cell carcinoma via EGFR/Akt/Wnt/β-catenin signaling axis.
Lee K; Chang JW; Oh C; Liu L; Jung SN; Won HR; Kim YI; Rha KS; Koo BS
Eur J Surg Oncol; 2020 Jun; 46(6):1066-1073. PubMed ID: 31864826
[TBL] [Abstract][Full Text] [Related]
18. KRAS mutations upregulate Runx1 to promote occurrence of head and neck squamous cell carcinoma.
Deng M; Guo J; Ling Z; Zhang C; He L; Fan Z; Cheng B; Xia J
Mol Carcinog; 2023 Sep; 62(9):1284-1294. PubMed ID: 37222390
[TBL] [Abstract][Full Text] [Related]
19. Targeting of EZH2 inhibits epithelial‑mesenchymal transition in head and neck squamous cell carcinoma via regulating the STAT3/VEGFR2 axis.
Zhao M; Hu X; Xu Y; Wu C; Chen J; Ren Y; Kong L; Sun S; Zhang L; Jin R; Zhou X
Int J Oncol; 2019 Nov; 55(5):1165-1175. PubMed ID: 31545422
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of the long non-coding RNA CASC9 as a biomarker for squamous cell carcinoma.
Sassenberg M; Droop J; Schulz WA; Dietrich D; Loick SM; Wiek C; Scheckenbach K; Gaisa NT; Hoffmann MJ
BMC Cancer; 2019 Aug; 19(1):806. PubMed ID: 31412811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]